Corrigendum

In the Review by Seyed Alireza Mahdaviani, Armin Hirbod-Mobarakeh, Ning Wang, Asgahr Aghamohammadi, Lennart Hammarström, Mohammad Reza Masjedi, Qiang Pan-Hammarström and Nima Rezaei, ‘Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome’, published in the August 2012 issue of Expert Review of Clinical Immunology (Expert Rev. Clin. Immunol. 8[6], 539–546 [2012]), on page 540, the following sentence was incorrectly printed as:

“The former mutation results in the replacement of glycine by valine at codon 133 (G133V) and is predicted to be probably damaging [101].”

The correct sentence should have been:

“The former mutation results in the replacement of glycine by valine at codon 125 (G125V), which is also predicted to be probably damaging (PolyPhen-2) [101].”

On page 541, Figure 1 was incorrectly printed as:

Figure 1. Novel mutation at the exon 3 of the AICDA gene.

The patient codon 133 has changed from GGG to GTG in the patients and their parents. Mutation analysis showed homozygous mutation in patients and heterozygous mutation in the parents.

The correct Figure 1 should have been:

Figure 1. Novel mutation at the exon 3 of the AICDA gene.

The patient codon 125 has changed from GGG to GTG in the patients and their parents. Mutation analysis showed homozygous mutation in patients and heterozygous mutation in the parents.

The authors and editors of Expert Review of Clinical Immunology would like to sincerely apologize for this oversight.